Detalhe da pesquisa
1.
Prognostic impact of infiltration of the vagina and/or uterus in women undergoing anterior pelvic exenteration for urothelial carcinoma of the bladder: results of a contemporary multicentre series.
World J Urol
; 33(3): 343-50, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24817140
2.
Anti-tumour activity of phosphoinositide-3-kinase antagonist AEZS-126 in models of ovarian cancer.
Arch Gynecol Obstet
; 291(1): 131-41, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25115278
3.
Mechanisms of tumor immune escape in triple-negative breast cancers (TNBC) with and without mutated BRCA 1.
Arch Gynecol Obstet
; 289(1): 141-7, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23828443
4.
Effects of lobaplatin as a single agent and in combination with TRAIL on the growth of triple-negative p53-mutated breast cancers in vitro.
Anticancer Drugs
; 23(4): 426-36, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22314264
5.
Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity.
Cancer Immunol Immunother
; 60(10): 1405-18, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21638125
6.
Papillary squamotransitional cell carcinoma of the vagina.
J Obstet Gynaecol Res
; 37(12): 1851-5, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21917071
7.
Induction of programmed cell death by inhibition of AKT with the alkylphosphocholine perifosine in in vitro models of platinum sensitive and resistant ovarian cancers.
Arch Gynecol Obstet
; 283(3): 603-10, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20405296
8.
Triple-negative breast cancers express receptors for growth hormone-releasing hormone (GHRH) and respond to GHRH antagonists with growth inhibition.
Breast Cancer Res Treat
; 116(2): 273-9, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18629632
9.
Tubulin inhibitor AEZS 112 inhibits the growth of experimental human ovarian and endometrial cancers irrespective of caspase inhibition.
Oncol Rep
; 22(2): 361-7, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19578778
10.
Antagonists of growth-hormone-releasing hormone: an emerging new therapy for cancer.
Nat Clin Pract Endocrinol Metab
; 4(1): 33-43, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18084344
11.
Perifosine inhibits growth of human experimental endometrial cancers by blockade of AKT phosphorylation.
Eur J Obstet Gynecol Reprod Biol
; 141(1): 64-9, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18687514
12.
Presurgical short term treatment of uterine fibroids with different doses of cetrorelix acetate: a double-blind, placebo-controlled multicenter study.
Eur J Obstet Gynecol Reprod Biol
; 134(2): 225-32, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16930803
13.
Human malignant melanomas express receptors for luteinizing hormone releasing hormone allowing targeted therapy with cytotoxic luteinizing hormone releasing hormone analogue.
Cancer Res
; 65(13): 5857-63, 2005 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15994963
14.
Effects of an Antagonistic Analog of Growth Hormone-Releasing Hormone on Endometriosis in a Mouse Model and In Vitro.
Reprod Sci
; 24(11): 1503-1511, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28205459
15.
Effective therapy of experimental human malignant melanomas with a targeted cytotoxic somatostatin analogue without induction of multi-drug resistance proteins.
Int J Oncol
; 28(6): 1507-13, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16685451
16.
Effective inhibition of experimental human ovarian cancers with a targeted cytotoxic bombesin analogue AN-215.
Clin Cancer Res
; 11(6): 2408-15, 2005 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15788692
17.
Receptors for luteinizing hormone releasing hormone expressed on human renal cell carcinomas can be used for targeted chemotherapy with cytotoxic luteinizing hormone releasing hormone analogues.
Clin Cancer Res
; 11(15): 5549-57, 2005 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16061872
18.
Targeting of Peptide Cytotoxins to LHRH Receptors For Treatment of Cancer.
Curr Drug Targets
; 17(5): 488-94, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26951061
19.
Targeted cytotoxic bombesin analog AN-215 effectively inhibits experimental human breast cancers with a low induction of multi-drug resistance proteins.
Endocr Relat Cancer
; 12(4): 999-1009, 2005 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-16322338
20.
Inhibition of growth of experimental human endometrial cancer by an antagonist of growth hormone-releasing hormone.
J Clin Endocrinol Metab
; 90(6): 3614-21, 2005 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15784701